nogrЭкспериментальная и клиническая гастроэнтерологияExperimental and Clinical Gastroenterology1682-8658«Global Media Technologies»10.31146/1682-8658-ecg-188-4-188-193nogr-1646Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL CASESАлгоритм диагностики латентной формы целиакии у взрослыхAlgorithm for diagnosing the latent form of celiac disease in adultsФедоренкоС. В.FedorenkoS. V.

Челябинск

Chelyabinsk

КовалеваЕ. Г.KovalevaE. G.

Челябинск

Chelyabinsk

ГранкинаО. Г.GrankinaO. G.

Челябинск

Chelyabinsk

ЛевинаТ. П.LevinaT. P.

Челябинск

Chelyabinsk

ЧумельА. Н.ChumelA. N.

Челябинск

Chelyabinsk

Клиника Вся медицина ЗАО «Медицинский центр ЧТПЗ»; ГБУЗ Областная клиническая больница № 3, отделение гастроэнтерологииРоссияClinic All Medicine CJSC “CHTPZ Medical Center”; Regional Clinical Hospital No. 3, Department of GastroenterologyRussian Federation20212007202104188193Copyright © Федоренко С.В., Ковалева Е.Г., Гранкина О.Г., Левина Т.П., Чумель А.Н., 20212021Федоренко С.В., Ковалева Е.Г., Гранкина О.Г., Левина Т.П., Чумель А.Н.Fedorenko S.V., Kovaleva E.G., Grankina O.G., Levina T.P., Chumel A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nogr.org/jour/article/view/1646

В статье представлен клинический случай латентного течения целиакии с установлением диагноза во взрослом периоде, отражена роль триггерных факторов, особенности клинического течения, формирования сопутствующей лактазной недостаточности и необходимость проведения всех диагностических этапов для постановки диагноза.

The article presents a clinical case of the latent course of celiac disease with diagnosis in the adult period, reflects the role of trigger factors, the features of the clinical course, the formation of concomitant lactase deficiency and the need for all diagnostic stages for diagnosis.

ReferencesLohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Th er. 2007;26(9):1217–25.Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26(9):1217–25.Стройкова МВ. Скрининг населения центрального региона России на антитела класса IgA к тканевой трансглутаминазе и применение данного метода обследования для диагностики целиакииу детей. М.; 2007.Stroykova MV. Screening of the population of the central region of Russia for IgA antibodies to tissue transglutaminase and the use of this examination method for the diagnosis of celiac disease in children. Moscow. 2007.Кондратьева ЕИ, Щербаков ПЛ, Бельмер СВ, Янкина ГН. О регистре больных целиакией. Сибирский вестник гепатологии и гастроэнтерологии. 2007;(20):67–8.Kondratyeva EI, Shcherbakov PL, Belmer SV, Yankina GN. About the register of patients with celiac disease. Siberian Bulletin of Hepatology and Gastroenterology. 2007; (20): 67–8.Tortora R, Zingone F, Rispo A, Bucci C, Capone P, Imperatore N, et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol. 2016;51(10):1179–83.Tortora R, Zingone F, Rispo A, Bucci C, Capone P, Imperatore N, et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol. 2016;51(10):1179–83.Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43–52.Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43–52.Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых. Альманах клинической медицины. 2016 Август- сентябрь; 44 (6): 661–688All- Russian consensus on the diagnosis and treatment of celiac disease in children and adults. Almanac of Clinical Medicine. 2016 August- September; 44 (6): 661–688.Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120(3):636–51.Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120(3):636–51.Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and notat-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and notat-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.Tortora R, Zingone F, Rispo A, Bucci C, Capone P, Imperatore N, et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol. 2016;51(10):1179–83.Tortora R, Zingone F, Rispo A, Bucci C, Capone P, Imperatore N, et al. Coeliac disease in the elderly in a tertiary centre. Scand J Gastroenterol. 2016;51(10):1179–83.Julio C. Bai J, CiacciC, Gino Roberto Corazza G. C, Fried M, Olano C, et al. Practice Guideline – Celiac Disease. World Gastroenterology Organisation. 2016.Julio C. Bai J, CiacciC, Gino Roberto Corazza G. C, Fried M, Olano C, et al. Practice Guideline – Celiac Disease. World Gastroenterology Organisation. 2016.Dickey W, McMillan SA, Hughes DF. Identification of coeliac disease in primary care. Scand J Gastroenterol. 1998;33(5):491–3.Dickey W, McMillan SA, Hughes DF. Identification of coeliac disease in primary care. Scand J Gastroenterol. 1998;33(5):491–3.Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician’s alertness to the condition essential. J ClinGastroenterol. 2007;41(2):152–6.Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician’s alertness to the condition essential. J ClinGastroenterol. 2007;41(2):152–6.Сарсенбаева А. С., Лазебник Л. Б. Диареи у взрослых. Клинические рекомендации. Проект. Экспери ментальная и клиническая гастроэнтерология 2020; 78 (6): 4–41.Sarsenbaevа A.S., Lazebnik L. B. Diarrhea in adults. Clinical guidelines. Project. Experimental and Clinical Gastroenterology. 2020;(6):4–41. (In Russ.) doi: 10.31146/1682–8658-ecg-178–6–4–41Клинические рекомендации РГА. Лечение больных с синдромом раздраженного кишечника. 2016.Clinical recommendations of the RSA. Treatment of patients with irritable bowel syndrome. 2016.Waugh N, Cummins E, Royle P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013;17: XV–XIX. Doi: 10.3310/hta17550Waugh N, Cummins E, Royle P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013;17: XV–XIX. Doi: 10.3310/hta17550Catassi C, Kryszak D, Louis- Jacques O, et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102(7):1454–60.Catassi C, Kryszak D, Louis- Jacques O, et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102(7):1454–60.V an der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing forceliac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303(17):1738–46. doi: 10.1001/jama.2010.549V an der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing forceliac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303(17):1738–46. doi: 10.1001/jama.2010.549Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998;4(6):713–7.Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998;4(6):713–7.Sollid LM, Lie BA. Celiac disease genetics: cur-rent concepts and practical applications. Clin Gastroenterol Hepatol. 2005;3(9):843–51.Sollid LM, Lie BA. Celiac disease genetics: cur-rent concepts and practical applications. Clin Gastroenterol Hepatol. 2005;3(9):843–51.Van de Wal Y, Kooy YM, van Veelen PA, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl AcadSci U S A. 1998;95(17):10050–4.Van de Wal Y, Kooy YM, van Veelen PA, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl AcadSci U S A. 1998;95(17):10050–4.Вохмянина Н. В. Алгоритм лабораторного мониторинга больных целиакией. Санкт- Петербург. 2002.Vokhmyanina N. V. Algorithm for laboratory monitoring of celiac patients. St. Petersburg. 2002. Вохмянина Н. В. Алгоритм лабораторного мониторинга больных целиакией. Санкт- Петербург. 2002.Rostami- Nejad M, Romanos J, Rostami K, et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World JGastroenterol. 2014;20(20):6302–8.Rostami- Nejad M, Romanos J, Rostami K, et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World JGastroenterol. 2014;20(20):6302–8.Gutierrez- Achury J, Zhernakova A, Pulit SL, Trynka G, Hunt KA, Romanos J, et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat Genet. 2015;47(6):577–8.Gutierrez- Achury J, Zhernakova A, Pulit SL, Trynka G, Hunt KA, Romanos J, et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat Genet. 2015;47(6):577–8.Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, et al. Analysis of HLA and nonHLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137(3):834–40, 840–3.Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, et al. Analysis of HLA and nonHLA alleles can identify individuals at high risk for celiac disease. Gastroenterology. 2009;137(3):834–40, 840–3.Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371(1):42–9.Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371(1):42–9.Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493–525.Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2011;29:493–525.

The authors declare that there are no conflicts of interest present.